PHRMASIPharmaceuticals
Pharmasia Ltd — Profit & Loss Statement
₹75.20
+0.00%
Pharmasia Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Tax Rate For Calcs | 0.01 | 0.05 | 0.12 | 0.01 | — |
| Normalized EBITDA | -1.27 Cr | -0.16 Cr | -1.04 Cr | -1.27 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -1.59 Cr | -0.52 Cr | -1.26 Cr | -1.55 Cr | — |
| Reconciled Depreciation | 0.32 Cr | 0.34 Cr | 0.36 Cr | 0.29 Cr | — |
| Reconciled Cost Of Revenue | 19.46 Cr | 24.61 Cr | 23.20 Cr | 14.38 Cr | — |
| EBITDA | -1.27 Cr | -0.16 Cr | -1.04 Cr | -1.27 Cr | — |
| EBIT | -1.59 Cr | -0.50 Cr | -1.40 Cr | -1.56 Cr | — |
| Net Interest Income | -0.02 Cr | -0.04 Cr | -0.03 Cr | 35000.00 | — |
| Interest Expense | 0.02 Cr | 0.04 Cr | 0.03 Cr | 39000.00 | — |
| Normalized Income | -1.59 Cr | -0.52 Cr | -1.26 Cr | -1.55 Cr | — |
| Net Income From Continuing And Discontinued Operation | -1.59 Cr | -0.52 Cr | -1.26 Cr | -1.55 Cr | — |
| Total Expenses | 26.70 Cr | 31.76 Cr | 29.39 Cr | 19.24 Cr | — |
| Diluted NI Availto Com Stockholders | -1.59 Cr | -0.52 Cr | -1.26 Cr | -1.55 Cr | — |
| Net Income Common Stockholders | -1.59 Cr | -0.52 Cr | -1.26 Cr | -1.55 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -1.59 Cr | -0.52 Cr | -1.26 Cr | -1.55 Cr | — |
| Net Income Including Noncontrolling Interests | -1.59 Cr | -0.52 Cr | -1.26 Cr | -1.55 Cr | — |
| Net Income Continuous Operations | -1.59 Cr | -0.52 Cr | -1.26 Cr | -1.55 Cr | — |
| Tax Provision | -0.01 Cr | -0.03 Cr | -0.17 Cr | -0.01 Cr | — |
| Pretax Income | -1.60 Cr | -0.55 Cr | -1.43 Cr | -1.56 Cr | — |
| Other Non Operating Income Expenses | 0.75 Cr | 0.66 Cr | 0.50 Cr | 0.46 Cr | — |
| Net Non Operating Interest Income Expense | -0.02 Cr | -0.04 Cr | -0.03 Cr | 35000.00 | — |
| Interest Expense Non Operating | 0.02 Cr | 0.04 Cr | 0.03 Cr | 39000.00 | — |
| Operating Income | -2.33 Cr | -1.16 Cr | -1.90 Cr | -2.03 Cr | — |
| Operating Expense | 7.25 Cr | 7.15 Cr | 6.19 Cr | 4.86 Cr | — |
| Other Operating Expenses | 5.01 Cr | 5.05 Cr | 2.15 Cr | 1.84 Cr | — |
| Depreciation And Amortization In Income Statement | 0.32 Cr | 0.34 Cr | 0.36 Cr | 0.29 Cr | — |
| Depreciation Income Statement | 0.32 Cr | 0.34 Cr | 0.11 Cr | 0.00 | — |
| Gross Profit | 4.91 Cr | 5.99 Cr | 4.29 Cr | 2.84 Cr | — |
| Cost Of Revenue | 19.46 Cr | 24.61 Cr | 23.20 Cr | 14.38 Cr | — |
| Total Revenue | 24.37 Cr | 30.59 Cr | 27.49 Cr | 17.22 Cr | — |
| Operating Revenue | 24.37 Cr | 30.59 Cr | 27.49 Cr | 17.22 Cr | — |
| Interest Income | — | 0.03 Cr | 0.02 Cr | 78000.00 | 0.02 Cr |
| Rent Expense Supplemental | — | 0.03 Cr | 0.02 Cr | 18000.00 | 18000.00 |
| Diluted Average Shares | — | 0.68 Cr | 0.68 Cr | 0.68 Cr | 0.68 Cr |
| Basic Average Shares | — | 0.68 Cr | 0.68 Cr | 0.68 Cr | 0.68 Cr |
| Diluted EPS | — | -0.76 | -1.84 | -2.27 | 0.46 |
| Basic EPS | — | -0.76 | -1.84 | -2.27 | 0.46 |
| Total Other Finance Cost | — | 0.02 Cr | 0.01 Cr | 4000.00 | 25618.00 |
| Interest Income Non Operating | — | 0.03 Cr | 0.02 Cr | 78000.00 | 0.02 Cr |
| Amortization | — | 0.23 Cr | 0.25 Cr | 0.29 Cr | 0.00 |
| Selling General And Administration | — | 0.40 Cr | 0.22 Cr | 0.13 Cr | 0.21 Cr |
| Selling And Marketing Expense | — | 0.24 Cr | 0.08 Cr | 0.03 Cr | 0.04 Cr |
| General And Administrative Expense | — | 0.16 Cr | 0.14 Cr | 0.10 Cr | 0.17 Cr |
| Rent And Landing Fees | — | 0.03 Cr | 0.02 Cr | 18000.00 | 18000.00 |
| Total Unusual Items | — | — | — | 0.00 | 0.00 |
| Total Unusual Items Excluding Goodwill | — | — | — | 0.00 | 0.00 |
| Special Income Charges | — | — | — | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Pharmasia Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.